Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$798M |
| 2 |
Netflix
NFLX
|
+$608M |
| 3 |
UnitedHealth
UNH
|
+$517M |
| 4 |
Apple
AAPL
|
+$461M |
| 5 |
GE Vernova
GEV
|
+$296M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$527M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$372M |
| 3 |
Meta Platforms (Facebook)
META
|
+$362M |
| 4 |
Advanced Micro Devices
AMD
|
+$328M |
| 5 |
Palantir
PLTR
|
+$327M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.57% |
| 2 | Healthcare | 15.79% |
| 3 | Consumer Discretionary | 12.36% |
| 4 | Financials | 11.53% |
| 5 | Industrials | 8.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1501
DELISTED
Aris Water Solutions
ARIS
| $5.22M | 0.01% |
220,600
-134,383
| -38% | -$3.32M |
2022 Q1
13 quarters
|
|
1502
Yatsen Holding
YSG
$242M
| $5.22M | 0.01% |
541,007
-4,700
| -0.9% | -$26.9K |
2021 Q3
15 quarters
|
|
1503
Tidewater
TDW
$4.28B
| $5.21M | 0.01% |
+112,883
| New | +$4.57M |
2025 Q2
0 quarters
|
|
1504
Invesco CurrencyShares Euro Currency Trust
FXE
$309M
| $5.2M | 0.01% |
+47,800
| New | +$5M |
2025 Q2
0 quarters
|
|
1505
Astec Industries
ASTE
$907M
| $5.18M | 0.01% |
124,145
-16,100
| -11% | -$611K |
2024 Q4
2 quarters
|
|
1506
Select STOXX Europe Aerospace & Defense ETF
EUAD
$989M
| $5.17M | 0.01% |
+119,800
| New | +$4.48M |
2025 Q2
0 quarters
|
|
1507
U-Haul Holding Co Series N
UHAL.B
$9.8B
| $5.17M | 0.01% |
95,000
-19,500
| -17% | -$1.09M |
2023 Q1
9 quarters
|
|
1508
SM Energy
SM
$8.95B
| $5.16M | 0.01% |
208,900
-478,963
| -70% | -$11.6M |
2021 Q3
15 quarters
|
|
1509
Lakeland Industries
LAKE
$98.5M
| $5.15M | 0.01% |
378,461
-39,808
| -10% | -$667K |
2014 Q4
42 quarters
|
|
1510
iShares 5-10 Year Investment Grade Corporate Bond ETF
IGIB
$18.8B
| $5.12M | 0.01% |
96,000
-124,600
| -56% | -$6.5M |
2025 Q1
1 quarter
|
|
1511
NETSTREIT Corp
NTST
$1.78B
| $5.11M | 0.01% |
302,100
-25,000
| -8% | -$400K |
2024 Q4
2 quarters
|
|
1512
Disc Medicine
IRON
$2.35B
| $5.11M | 0.01% |
96,420
-94,800
| -50% | -$4.45M |
2024 Q4
2 quarters
|
|
1513
Inogen
INGN
$170M
| $5.1M | 0.01% |
726,106
-4,694
| -0.6% | -$31.6K |
2014 Q4
42 quarters
|
|
1514
Eastern Bankshares
EBC
$4.86B
| $5.1M | 0.01% |
334,104
+314,882
| +1,638% | +$4.73M |
2021 Q2
16 quarters
|
|
1515
Ardelyx
ARDX
$831M
| $5.1M | 0.01% |
1,301,193
-50,400
| -4% | -$208K |
2025 Q1
1 quarter
|
|
1516
Huckleberry.ai, Inc. Class B Common Stock
HUCK
$145M
| $5.1M | 0.01% |
364,887
+251,707
| +222% | +$2.53M |
2020 Q2
20 quarters
|
|
1517
Graphic Packaging
GPK
$2.43B
| $5.1M | 0.01% |
+241,918
| New | +$5.59M |
2025 Q2
0 quarters
|
|
1518
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
$121M
| $5.1M | 0.01% |
106,078
+38,200
| +56% | +$2.25M |
2024 Q4
2 quarters
|
|
1519
Bausch Health
BHC
$2.23B
| $5.07M | 0.01% |
760,983
-148,589
| -16% | -$764K |
2024 Q3
3 quarters
|
|
1520
iShares MSCI Canada ETF
EWC
$7.16B
| $5.06M | 0.01% |
+109,600
| New | +$4.74M |
2025 Q2
0 quarters
|
|
1521
GraniteShares Gold Shares
BAR
$1.36B
| $5.06M | 0.01% |
155,100
-404,600
| -72% | -$13.1M |
2023 Q4
6 quarters
|
|
|
CNTA
1522
DELISTED
Centessa Pharmaceuticals
CNTA
| $5.06M | 0.01% |
384,900
+206,900
| +116% | +$2.62M |
2023 Q1
9 quarters
|
|
1523
Compañía de Cervecerías Unidas
CCU
$2.02B
| $5.05M | 0.01% |
391,065
-18,500
| -5% | -$263K |
2017 Q2
32 quarters
|
|
1524
Evolution Petroleum
EPM
$149M
| $5.04M | 0.01% |
1,072,897
-23,400
| -2% | -$106K |
2013 Q2
48 quarters
|
|
1525
DELISTED
89bio
ETNB
| $5.04M | 0.01% |
513,400
+9,100
| +2% | +$75.3K |
2024 Q2
4 quarters
|
|
Similar funds
Renaissance Technologies's Q2 2025 Portfolio in Review
As of Q2 2025, Renaissance Technologies held 4,018 positions worth $75.2B, up 14% from $66.1B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Renaissance Technologies's Q2 2025 filing shows 612 new, 1,577 increased, 1,314 reduced and 496 closed positions. Its largest new stake was UnitedHealth: 1,352,129 shares worth $422M. The largest sale was Broadcom, an estimated $527M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Renaissance Technologies's largest Q2 2025 buy was UnitedHealth: 1,352,129 shares worth $422M.
- Renaissance Technologies added most to NVIDIA in Q2 2025, an estimated $798M increase.
- Renaissance Technologies's biggest Q2 2025 reduction was Broadcom, cutting an estimated $527M.
- Renaissance Technologies fully exited Advanced Micro Devices in Q2 2025, selling an estimated $328M.
- Renaissance Technologies's ten largest holdings make up 12% of its $75.2B portfolio in Q2 2025.
- Renaissance Technologies opened 612 new positions and closed 496 in Q2 2025.
- Renaissance Technologies's portfolio value rose 14% quarter-over-quarter to $75.2B.
Based on Renaissance Technologies's 13F filing for Q2 2025, filed 13 Aug 2025.